Summary

Eligibility
for people ages up to 80 years (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
completion around
Principal Investigator
by Paul Brakeman, MD, PhD
Headshot of Paul Brakeman
Paul Brakeman

Description

Summary

Official Title

Nephrotic Syndrome Study Network Under the Rare Diseases Clinical Research Network

Details

Keywords

Minimal Change Disease (MCD), Membranous Nephropathy, Glomerulosclerosis, Focal Segmental, Focal and Segmental Glomerulosclerosis, Focal & Segmental Glomerulosclerosis, Focal Segmental Glomerulosclerosis, FSGS, Minimal change disease, MCD, MN, Nephrotic Syndrome, Neph Syndrome, NEPTUNE, NephCure, Halpin, Kidney Diseases, Nephrosis, Membranous Glomerulonephritis, Lipoid Nephrosis, Syndrome, Kidney Biopsy

Eligibility

Locations

  • UCSF Benioff Children's Hospitals not yet accepting patients
    San Francisco California 94158 United States
  • Stanford University School of Medicine accepting new patients
    Palo Alto California 94304 United States
  • University of Southern California-Children's Hospital accepting new patients
    Los Angeles California 90227 United States

Lead Scientist at UCSF

  • Paul Brakeman, MD, PhD
    Professor, Pediatrics, School of Medicine. Authored (or co-authored) 45 research publications

Details

Status
accepting new patients at some sites,
but this study is not currently recruiting here
Start Date
Completion Date
(estimated)
Sponsor
University of Michigan
Links
Rare Diseases Clinical Research Networks Homepage Patient Advocacy group for FSGS/MCD Patient advocacy group for MN The NEPTUNE Study Homepage
ID
NCT01209000
Study Type
Observational
Participants
Expecting 1200 study participants
Last Updated